Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer (Q39652928)

13 September 2017

Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer (English)

1 reference

13 September 2017

1 reference

1 reference

Jan Bouchal

1

1 reference

13 September 2017

Frédéric R Santer

2

1 reference

13 September 2017

Philipp P S Höschele

3

1 reference

13 September 2017

Eva Tomastikova

4

1 reference

13 September 2017

Hannes Neuwirt

5

1 reference

13 September 2017

Zoran Culig

6

1 reference

13 September 2017

language of work or name

1 reference

21 September 2010

1 reference

13 September 2017

1 reference

13 September 2017

71

1 reference

13 September 2017

4

1 reference

13 September 2017

431-437

1 reference

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Androgen deprivation increases p300 expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

p300 modulates nuclear morphology in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Cellular and physiological effects of soy flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Soy isoflavones and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21257

21 January 2018

Identifiers

DOI

10.1002/PROS.21257

1 reference

13 September 2017

1 reference